Skip to main content

Table 2 Hematological parameters of SHIV89.6-infected Ch-RMs during Aikeqing treatment

From: Aikeqing decreases viral loads in SHIV89.6-infected Chinese rhesus macaques

Markers

Group

Weeks post administration of AKQ

0

2

4

WBC

H

7.2 ± 2.0

8.1 ± 0.8

7.2 ± 1.1

L

7.0 ± 1.6

8.2 ± 0.4

8.4 ± 0.6

C

7.6 ± 1.9

8.0 ± 2.0

7.3 ± 2.3

Mon (%)

H

7.3 ± 0.7

8.1 ± 2.2

7.7 ± 2.1

L

7.9 ± 0.9

8.9 ± 1.6

7.6 ± 0.9

C

7.6 ± 1.1

8.1 ± 1.3

8.2 ± 0.3

Mon (109/L)

H

0.4 ± 0.1

0.5 ± 0.1

0.4 ± 0.2

L

0.4 ± 0.2

0.4 ± 0.4

0.4 ± 0.2

C

0.6 ± 0.3

0.4 ± 0.3

0.7 ± 0.2

RDW (%)

H

15.6 ± 0.3

16.4 ± 0.4

15.5 ± 0.1

L

15.8 ± 0.3

16.1 ± 0.3

15.5 ± 0.8

C

14.7 ± 0.6

16.2 ± 0.2

15.5 ± 1.0

RBC (1012/L)

H

7.5 ± 0.4

6.6 ± 0.4

6.8 ± 0.1

L

7.1 ± 0.4

5.6 ± 0.4

6.0 ± 0.6

C

7.1 ± 0.3

6.0 ± 0.9

5.8 ± 0.8

HCT (%)

H

58.7 ± 2.0

51.2 ± 3.4

53.9 ± 1.0

L

53.2 ± 2.9

42.8 ± 3.2

46.7 ± 4.9

C

52.9 ± 2.4

46.0 ± 7.2

45.6 ± 7.0

Lym (109/L)

H

1.7 ± 0.3

2.0 ± 0.2

2.5 ± 0.5

L

1.5 ± 0.2

1.6 ± 0.6

2.0 ± 0.3

C

1.8 ± 0.5

1.8 ± 0.7

2.0 ± 0.3

Lym (%)

H

22.4 ± 6.0

27.3 ± 10.5

36.9 ± 12.5

L

19.0 ± 9.7

17.4 ± 5.9

34.0 ± 7.8

C

22.8 ± 12.4

23.2 ± 22.0

32.7 ± 13.9

MCV (fL)

H

74.6 ± 0.2

77.5 ± 0.5

79.0 ± 0.3

L

75.0 ± 0.5

76.9 ± 0.4

78.6 ± 0.2

C

74.3 ± 0.5

77.3 ± 0.8

78.5 ± 1.5

MCH (pg)

H

24.4 ± 0.4

25.6 ± 0.6

26.8 ± 0.5

L

23.9 ± 1.2

25.0 ± 0.3

26.2 ± 0.2

C

22.9 ± 1.9

24.1 ± 1.9

24.2 ± 2.4

MCHC (g/L)

H

328.3 ± 4.2

331.3 ± 7.8

339.3 ± 6.7

L

319.3 ± 13.9

326.0 ± 4.4

333.3 ± 3.2

C

309.0 ± 23.4

311.7 ± 22.0

308.3 ± 26.5

MPV (fL)

H

7.2 ± 0.1

7.8 ± 0.6

8.0 ± 0.5

L

7.3 ± 0.1

7.9 ± 0.4

8.1 ± 0.3

C

6.9 ± 0.5

8.1 ± 0.5

7.6 ± 0.5

HGB (g/L)

H

189.7 ± 5.0

176.3 ± 4.5

183.0 ± 1.0

L

170.0 ± 9.6

149.7 ± 8.1

156.0 ± 15.6

C

160.7 ± 14.2

158.0 ± 24.5

152.0 ± 24.8

PDW

H

16.5 ± 0.1

16.6 ± 0.3

16.6 ± 0.2

L

16.8 ± 0.5

16.3 ± 0.2

16.3 ± 0.2

C

16.6 ± 0.1

16.3 ± 0.2

16.2 ± 0.2

PLT (109/L)

H

410.0 ± 76.3

367.0 ± 60.9

287.7 ± 27.1

L

331.7 ± 27.7

440.3 ± 67.3

372.7 ± 61.2

C

418.0 ± 25.0

459.7 ± 24.0

377.7 ± 51.9

PCT (%)

H

0.3 ± 0.1

0.3 ± 0.0

0.2 ± 0.0

L

0.2 ± 0.1

0.4 ± 0.1

0.3 ± 0.1

C

0.2 ± 0.1

0.4 ± 0.0

0.3 ± 0.1

Gran (109/L)

H

3.8 ± 0.7

5.6 ± 4.6

2.9 ± 1.4

L

2.9 ± 0.2

4.4 ± 2.0

2.2 ± 1.3

C

2.4 ± 0.8

4.6 ± 1.5

2.7 ± 0.7

Gran (%)

H

71.3 ± 7.1

63.9 ± 6.6

58.1 ± 12.6

L

72.8 ± 8.2

71.0 ± 7.7

60.0 ± 7.5

C

70.3 ± 14.0

69.6 ± 12.5

64.5 ± 8.4

  1. H high-dose group, L low-dose group, C control group, WBC white blood cells, Mon monocytes, RDW red blood cell volume distribution width, RBC red blood cells, HCT haematocrit, Lym lymphocytes, MCV mean corpuscular volume, MCH mean corpuscular haemoglobin, MCHC mean corpusular hemoglobin concerntration, MPV mean platelet volume, HGB haemoglobin, PDW platelet distribution width, PLT platelets, PCT plateletcrit, Gran granulocytes